EMFO LLC’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $205K | Hold |
11,500
| – | – | 0.18% | 90 |
|
|
2024
Q1 | $175K | Hold |
11,500
| – | – | 0.16% | 101 |
|
|
2023
Q4 | $196K | Hold |
11,500
| – | – | 0.18% | 91 |
|
|
2023
Q3 | $96.1K | Hold |
11,500
| – | – | 0.09% | 123 |
|
|
2023
Q2 | $286K | Hold |
11,500
| – | – | 0.26% | 73 |
|
|
2023
Q1 | $173K | Hold |
11,500
| – | – | 0.16% | 95 |
|
|
2022
Q4 | $136K | Sell |
11,500
-2,000
| -15% | -$23.7K | 0.14% | 106 |
|
|
2022
Q3 | $80K | Hold |
13,500
| – | – | 0.08% | 148 |
|
|
2022
Q2 | $57K | Sell |
13,500
-1,000
| -7% | -$4.22K | 0.06% | 174 |
|
|
2022
Q1 | $138K | Hold |
14,500
| – | – | 0.13% | 129 |
|
|
2021
Q4 | $276K | Hold |
14,500
| – | – | 0.24% | 87 |
|
|
2021
Q3 | $483K | Hold |
14,500
| – | – | 0.43% | 54 |
|
|
2021
Q2 | $562K | Buy |
+14,500
| New | +$562K | 0.49% | 49 |
|